Ardelyx, Inc. SEC filings ARDX
Ardelyx, Inc. has 1,006 filings in SEC EDGAR's recent list, going back to Jan 14, 2016. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | May 26, 2026 | — |
| DEFA14A | Additional proxy material | May 19, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 16, 2026 |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 18, 2025 |
| DEFA14A | Additional proxy material | Jun 4, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 14, 2024 |
| DEFA14A | Additional proxy material | Jun 5, 2023 | — |
| DEF 14A | Proxy statement | Apr 26, 2023 | Jun 15, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2023 | Jun 15, 2023 |
| DEFA14A | Additional proxy material | Jul 1, 2022 | — |
| DEFA14A | Additional proxy material | Jun 8, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 15, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2022 | Jun 15, 2022 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 16, 2021 |
| DEFA14A | Additional proxy material | Apr 27, 2020 | — |
| DEF 14A | Proxy statement | Apr 27, 2020 | Jun 9, 2020 |
| DEFA14A | Additional proxy material | Apr 26, 2019 | — |
| DEF 14A | Proxy statement | Apr 26, 2019 | Jun 13, 2019 |
| DEF 14A | Proxy statement | Apr 26, 2018 | Jun 13, 2018 |
| DEFA14A | Additional proxy material | Apr 26, 2018 | — |
| DEFA14A | Additional proxy material | Apr 27, 2017 | — |
| DEFA14A | Additional proxy material | Apr 25, 2017 | — |
| DEF 14A | Proxy statement | Apr 25, 2017 | Jun 7, 2017 |
| DEFA14A | Additional proxy material | Apr 22, 2016 | — |
| DEF 14A | Proxy statement | Apr 22, 2016 | Jun 2, 2016 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARDX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Fremont, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1437402
- Former names
- NTERYX INC (until Jun 9, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.